Neonc Technologies (NASDAQ:NTHI) Stock: Insider Amir Heshmatpour Buys 30,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 30,000 shares of the business’s stock in a transaction dated Friday, November 13th. The shares were purchased at an average cost of $5.02 per share, for a total transaction of $150,600.00. Following the completion of the purchase, the chief executive officer directly owned 3,353,000 shares of the company’s stock, valued at approximately $16,832,060. This represents a 0.90% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Neonc Technologies Price Performance

Shares of NASDAQ:NTHI traded up $0.06 during mid-day trading on Friday, reaching $4.91. 251,853 shares of the company’s stock were exchanged, compared to its average volume of 118,828. Neonc Technologies Holdings, Inc. has a twelve month low of $2.50 and a twelve month high of $11.38. The business’s fifty day moving average price is $3.30 and its 200-day moving average price is $5.29.

Neonc Technologies (NASDAQ:NTHI) last announced its earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.03).

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Roth Capital started coverage on Neonc Technologies in a research report on Thursday, September 24th. They set a “buy” rating for the company. BTIG Research reissued a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a report on Tuesday, September 8th. Weiss Ratings lowered shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, October 21st. Wall Street Zen upgraded shares of Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Finally, Zacks Research raised shares of Neonc Technologies from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 5th. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Neonc Technologies presently has an average rating of “Moderate Buy” and an average price target of $16.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of NTHI. Bank of America Corp DE bought a new stake in Neonc Technologies in the 2nd quarter worth approximately $1,017,000. BlackRock Inc. bought a new position in Neonc Technologies during the second quarter valued at approximately $815,000. Global Retirement Partners LLC bought a new position in Neonc Technologies during the second quarter valued at approximately $126,000. Finally, Westmount Partners LLC raised its stake in shares of Neonc Technologies by 355.2% during the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after acquiring an additional 153,858 shares in the last quarter.

About Neonc Technologies

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.